Pathology Instruments Market Size to Grow by $ 1.23 bn During 2021-2025
Technavio has been monitoring the pathology instruments market and it is expected to grow by $ 1.23 bn, accelerating at a CAGR of almost 6% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking
Pathology Instruments Market: Receive Free Sample Report
Pathology Instruments Market: North America to lead market growth during the forecast period
Pathology Instruments Market: Key Competitors
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Co., Bio SB, Bio-Rad Laboratories, Inc, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., and PHC Holdings Corporation are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
For more insights on this market: Download a Free Sample Report
Pathology Instruments Market: Key Highlights of the Report for 2021-2025
The Global Pathology Instruments Market is expected to grow by $ 1.23 billion and accelerate at a CAGR of over 6% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. View our Free Sample Report
Pathology Instruments Market: Segmentation by Application
During 2020, the diagnostics segment dominated the Global Pathology Instruments Market. The rising need for early and accurate diagnostics will drive the growth of the market in diagnostic application segment. However, the market segment will record a slow growth rate during the forecast period. The growing incidence and prevalence of cancer is one of the primary growth factors driving the pathology instruments market.
To reduce the spread and prevalence of cancer, it is imperative that the disease is identified and controlled at an early stage. Early diagnosis helps in stopping the growth and spread of the cancerous cells which leads to better outcomes. Since pathology instruments are equipped with strong principles of detection that accurately diagnose the disease and guide towards appropriate treatment, the need for the early diagnosis of cancer will drive the pathology instruments market revenue.
Pathology Instruments Market: Vendor Analysis
The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Co., Bio SB, Bio-Rad Laboratories, Inc, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., and PHC Holdings Corporation are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio forecasts three scenarios (optimistic, probable, and pessimistic) to evaluate the impact of COVID-19 Download a Free Sample Report. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.
